Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure.

Chin KK, Ball BJ, Abaza Y, Altman JK, Thakur RK, Ali M, Derkach A, Geyer MB, Goldberg AD, Haque TZ, Thompson MC, Park JH, Tallman MS, Cai SF, Wang ES, Aldoss IT, Stein EM

Open source

DOI: 10.1182/bloodadvances.2025018178
Published: 2026 Mar 10
Container: Blood advances
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2025018178,
  title = {Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure.},
  author = {Chin KK and Ball BJ and Abaza Y and Altman JK and Thakur RK and Ali M and Derkach A and Geyer MB and Goldberg AD and Haque TZ and Thompson MC and Park JH and Tallman MS and Cai SF and Wang ES and Aldoss IT and Stein EM},
  year = {2026},
  journal = {Blood advances},
  doi = {10.1182/bloodadvances.2025018178},
  url = {https://doi.org/10.1182/bloodadvances.2025018178}
}

RIS

TY  - JOUR
TI  - Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure.
AU  - Chin KK
AU  - Ball BJ
AU  - Abaza Y
AU  - Altman JK
AU  - Thakur RK
AU  - Ali M
AU  - Derkach A
AU  - Geyer MB
AU  - Goldberg AD
AU  - Haque TZ
AU  - Thompson MC
AU  - Park JH
AU  - Tallman MS
AU  - Cai SF
AU  - Wang ES
AU  - Aldoss IT
AU  - Stein EM
PY  - 2026
JO  - Blood advances
DO  - 10.1182/bloodadvances.2025018178
UR  - https://doi.org/10.1182/bloodadvances.2025018178
ER  -

APA

KK, C., BJ, B., Y, A., JK, A., RK, T., M, A., A, D., MB, G., AD, G., TZ, H., MC, T., JH, P., MS, T., SF, C., ES, W., IT, A., & EM, S. (2026). Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure.. Blood advances. https://doi.org/10.1182/bloodadvances.2025018178

Source records

pubmed · retrieved 2026-09-26T06:50:35.877Z